Kapstone Financial Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Kapstone Financial Advisors's ELV Position: Q2 2026 in Review
Kapstone Financial Advisors opened a new position in Elevance Health (ELV) in Q2 2026: 595 shares worth $230K. The stake represents 0.1% of the portfolio and ranks #147 among its holdings. This is a return to the name: Kapstone Financial Advisors previously reported a position in ELV as recently as Q4 2025.
Kapstone Financial Advisors first reported a position in ELV in Q4 2022 and has held it in 14 quarters since. The position peaked at $919K in Q2 2024. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Kapstone Financial Advisors held 595 shares of Elevance Health worth $230K as of Q2 2026.
- Elevance Health was a new Kapstone Financial Advisors position in Q2 2026.
- Elevance Health made up 0.1% of Kapstone Financial Advisors's portfolio in Q2 2026, its #147 holding.
- Kapstone Financial Advisors first reported a position in Elevance Health in Q4 2022 and has held it in 14 quarters since.
- Kapstone Financial Advisors's Elevance Health position peaked at $919K in Q2 2024.
- 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Kapstone Financial Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.